Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Nanoscale Advances|September 22, 2022
Low reflectance of carbon nanotube and nanoscroll-based thin film coatings: a case studySonia Saini, S Reshmi, Girish M Gouda, et al.Indian Pediatrics|January 7, 2021
Clinical Profile of Adolescent Onset Anorexia Nervosa at a Tertiary Care CenterKavitha Esther Prasad, Roshni Julia Rajan, Mona M Basker, et al.Cureus|October 20, 2025
An Investigation of the Effectiveness of the Family Adoption Program Among Undergraduate Medical StudentsPanchasheela S Reshmi, Geeta K Patel, Harsh K Patel, et al.Cancer Genetics and Cytogenetics|February 12, 1999
Increased karyotype precision using fluorescence in situ hybridization and spectral karyotyping in patients with myeloid malignanciesE W Fleischman, S Reshmi, O I Sokova, et al.Proceedings of the National Academy of Sciences of the United States of America|August 5, 1997
MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3)O M Sobulo, J Borrow, R Tomek, et al.Genes, Chromosomes & Cancer|January 14, 1999
MLL is involved in a t(2;11)(p21;q23) in a patient with acute myeloblastic leukemiaE W Fleischman, S Reshmi, M A Frenkel, et al.Blood|January 7, 1998
Heterogeneity in the breakpoints in balanced rearrangements involving band 12p13 in hematologic malignancies identified by fluorescence in situ hybridization: TEL (ETV6 ) is involved in only one halfY Sato, S K Bohlander, H Kobayashi, et al.Blood|July 15, 1997
All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disordersJ D Rowley, S Reshmi, O Sobulo, et al.Cancer Genetics and Cytogenetics|April 24, 1999
Variant three-way translocation of inversion 16 in AML-M4Eo confirmed by fluorescence in situ hybridization analysisJ A Martinez-Climent, A M Comes, E Vizcarra, et al.Pageof 2